AI assistant
Sending…
DEXCOM INC — Director's Dealing 2014
Apr 29, 2014
30198_dirs_2014-04-29_90042163-be71-4e03-99fc-76ab12e5cb8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-04-25
Reporting Person: MOY JEFFREY (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-25 | Common Stock | M | 3097.0 | $7.63 | Acquired | 144662 | Indirect |
| 2014-04-25 | Common Stock | M | 2000.0 | $9.36 | Acquired | 146662 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-25 | Incentive Stock Option (right to buy) | $7.63 | M | 3097.0 | Disposed | 2018-05-19 | Common Stock (3097) | Direct |
| 2014-04-25 | Incentive Stock Option (right to buy) | $9.36 | M | 2000.0 | Disposed | 2017-09-20 | Common Stock (2000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 97916 | Direct |
Footnotes
F1: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17